Migraine and angiotensin-converting enzyme association in Turkish patients

Pain Clinic

Volumn 15, Issue 4, 2003, Pages 473-477

  Cakmak, Ecir Ali ^a   Cataloluk, Osman ^a   Yoldas, Tahir ^b   Arslan, Ahmet ^a   Herken, Hasan ^a   Barlas, Omer ^a   Gorucu, Senay ^a   Yigiter, Remzi ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

ACE; Genetics; Migraine; PCR

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; TURKEY (REPUBLIC);

EID: 0344009600     PISSN: 01691112     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856903770196881     Document Type: Article

References (14)

1. Ferrari MD, Haan J, The genetics of migraine: implication for treatment approaches, J Neural Transm Suppl 63, 111-27 (2002).
2. Yilmaz M, Erdal ME, Herken H, et al., Significance of the seretonin transporter gene polymorphism in migraine, J Neurol Sci 186, 27-30 (2001).
3. Kaiser F, Anticipation in migraine with affective psychosis, Amer J Med Genet 110, 62-4 (2002).
4. Mucke H, Therapies in development for the treatment of migraine, Expert Opin Investig Drugs 11, 1813-20 (2002).
5. Jenkins TA, Mendelsohn FA, Chai SY, Angiotensin-converting enzyme modulates dopamine turnover in the striatum, J Neurochem 68, 1304-11 (1997).
6. Svensson DA, Larsson B, Waldenlind E, et al., Genetic and environmental influences on expression of recurrent headache as a function of the reporting age in twins, Twin Res 5, 277-86 (2002).
7. Rigat B, Hubert C, Corvol P, et al., PCR detection of the insertion/deletion polymorphism in the human angiotensin converting enzyme gene, Nucl Acids Res 20, 1433 (1992).
8. Kario K, Kanai N, Saito K, Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives, Circulation 93, 1630-3 (1996).
9. Cambien F, Poirier O, Lecerf L, Deletion polymorphism at the angiotensin-converting enzyme gene is a potent risk factor for myocardial infarction, Nature 359, 641-4 (1992).
10. Cataloluk O, Nacak M, Savas HA, et al., Angiotensin converting enzyme gene polymorphism and its association to bipolar affective disorder in Turkish patients, Neurol Psychiatry and Brain Res 10 (3), (2003).
11. Segman RH, Shapira Y, Kanyas K, et al., Angiotensin-converting enzyme polymorphism in schizophrenia and major affective disorder: population and family based association-studies, Am J Med Genet 81, 522-3 (1998).
12. Paterna S, Di Pasquale P, D'Angelo A, et al., Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura, Eur Neurol 43, 133-6 (2000).
13. Ivanor VM-L, Alexandre CP, Gloria FAM, et al., Angiotensinogen and angiotensin converting enzyme gene polymorphisms and the risk of bipolar affective disorder in humans, Neurosci Lett 293, 103-6 (2000).
14. Arinami T, Li L, Mitsushio H, et al., An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders, Biol Psychiatry 40, 1122-7 (1996).